Deyao Zhang
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Interpreting the pT1 subgroup in the ASTER 70s trial.
Journal: Lancet (London, England)
Published: August 03, 2025
Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
Journal: Journal of cellular and molecular medicine
Published: December 21, 2022
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Journal: International immunopharmacology
Published: November 28, 2022
A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy.
Journal: Journal of inflammation research
Published: November 13, 2022
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Journal: Journal of clinical medicine
Published: November 03, 2022
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Journal: International immunopharmacology
Published: October 24, 2022
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
Journal: Journal of inflammation research
Published: October 14, 2022
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
Journal: Journal of personalized medicine
Published: October 09, 2022
Exploring better stratification methods for individualized treatment of patients with colorectal cancer liver metastases.
Journal: Annals of palliative medicine
Published: June 19, 2022
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: June 23, 2021
Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
Journal: BMC cancer
Published: February 06, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026